News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bayer HealthCare Pharmaceuticals (BAY) Drug Delays MS In Half Of Patients: National Institute Of Neurological Disorders MRI Study



11/11/2008 7:44:38 AM

CHICAGO (Reuters) - A long-term study of brain scans in multiple sclerosis patients showed only about half of the patients who took the drug interferon beta 1-b got a long-lasting benefit, U.S. researchers said on Monday.

Read at Reuters
Read at MedPageToday
Read at EurekAlert!

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES